CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted ImmunotherapyCLDN6在卵巢癌中的表达可塑性：CLDN6靶向免疫疗法治疗优化方面的见解Cancer Research CommunicationsIF02026-02-011PRE
SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62024-10-140OAAI
CLDN6: Biological insight into therapeutic potency of SAIL66, a next generation of T-cell engager targeting CLDN6CANCER RESEARCHIF16.62024-03-220PRE
SAIL66, a next generation T cell engager targeting CLDN6, potentiates efficacy by binding to CD3/CD137CANCER RESEARCHIF16.62024-03-220PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向